Similarly, in bladder cancer, GSTM5 acts as a tumor suppressor, and its promoter hypermethylation results in decreased expression, reduced glutathione levels, and enhanced tumor progression [21]. The gene discussed is GSTM5; the disease is urinary bladder carcinoma.